Literature DB >> 22180527

Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors.

Tvrtko Hudolin1, Zeljko Kastelan, Nikola Knezevic, Eleonora Goluza, Davor Tomas, Marijana Coric.   

Abstract

Eighty-five patients had staging laparoscopic retroperitoneal lymph node dissection (L-RPLND) for nonseminomatous germ cell tumors at our institution. The largest lymph node size was measured and presence or absence of metastatic disease was determined. A total of 1139 lymph nodes have been removed and in 27 (31.8%) patients, metastases in one or more lymph nodes were detected. There were 338 (29.7%) hilar, 259 (22.7%) paraaortic, 221 (19.4%) interaortocaval, 171 (15%) paracaval, 133 (11.7%) preaortic and 17 (1.5%) precaval lymph nodes. The total number of lymph nodes with metastases was 74 (6.5%), and 1065 (93.5%) nodes did not have any metastases. The average size of a lymph node with metastases was 1.05 (0.3-3), and without metastases it was 0.55 (0.1-2.5) cm, (p<0.001). If we use > 1 cm size of a lymph node as a "cut-off" value for enlargement and presence of metastases, 60% of metastatic lymph nodes would be missed since they were all ≤ 1 cm. Our results have shown that decreasing size of lymph nodes which are considered positive from > 1 cm to 0.7 -0.8 cm can be recommended, with specificity and sensitivity equal 70%.

Entities:  

Mesh:

Year:  2011        PMID: 22180527     DOI: 10.1177/1066896911431452

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  9 in total

1.  Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.

Authors:  Shiyu Tong; Minfeng Chen; Xiongbing Zu; Yuan Li; Wei He; Ye Lei; Wentao Liu; Lin Qi
Journal:  Int Urol Nephrol       Date:  2013-09-01       Impact factor: 2.370

2.  Management of testicular cancer: NYU case of the month, March 2017.

Authors:  James S Wysock
Journal:  Rev Urol       Date:  2017

Review 3.  Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.

Authors:  Gregory A Joice; Steven P Rowe; Michael A Gorin; Phillip M Pierorazio
Journal:  Curr Urol Rep       Date:  2018-11-09       Impact factor: 3.092

Review 4.  Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors.

Authors:  Salim K Cheriyan; Marilin Nicholson; Ahmet M Aydin; Mounsif Azizi; Charles C Peyton; Wade J Sexton; Scott M Gilbert
Journal:  Transl Androl Urol       Date:  2020-01

5.  Magnetic resonance versus computed tomography for the detection of retroperitoneal lymph node metastasis due to testicular cancer: A systematic literature review.

Authors:  Andrés Felipe Herrera Ortiz; Lorena Josefina Fernández Beaujon; Sandra Yulitza García Villamizar; Freddy Fernando Fonseca López
Journal:  Eur J Radiol Open       Date:  2021-08-17

6.  OCT4 immunohistochemistry after staging laparoscopic retroperitoneal lymphadenectomy for testicular tumor.

Authors:  Nikola Knežević; Tomislav Kuliš; Luka Penezić; Marijana Ćorić; Ivan Krhen; Željko Kaštelan
Journal:  Acta Clin Croat       Date:  2019-06       Impact factor: 0.780

Review 7.  Intricacies of Radiographic Assessment in Testicular Germ Cell Tumors.

Authors:  Marek Makovník; Katarína Rejleková; Ivan Uhrin; Michal Mego; Michal Chovanec
Journal:  Front Oncol       Date:  2021-01-05       Impact factor: 6.244

Review 8.  The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and Pitfalls.

Authors:  Thibaut Pierre; Fatine Selhane; Elise Zareski; Camilo Garcia; Karim Fizazi; Yohann Loriot; Anna Patrikidou; Natacha Naoun; Alice Bernard-Tessier; Hervé Baumert; Cédric Lebacle; Pierre Blanchard; Laurence Rocher; Corinne Balleyguier
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

Review 9.  Lymph node imaging in testicular cancer.

Authors:  Graham R Hale; Seth Teplitsky; Hong Truong; Samuel A Gold; Jonathan B Bloom; Piyush K Agarwal
Journal:  Transl Androl Urol       Date:  2018-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.